SARAH GRUIS: Open Payments
NPI 1649982083 · ERWIN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 18 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $71 |
| Lilly USA, LLC | 3 | $51 |
| Novo Nordisk Inc | 2 | $32 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Boston Scientific Corporation | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: MOUNJARO, Rybelsus, TRELEGY ELLIPTA, JARDIANCE, WaveWriter Alpha Prime 16, QULIPTA, INSPIRE, CREON.
Industry payments across NC — which companies pay providers there.
